Related Experiment Video

Updated: Mar 13, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K

Ex vivo gene therapy in France

F Morinet1, J Larghero1

  • 1Université Paris Diderot Paris 7, pôle biologie-pathologie-physiologie (B2P), groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Current Research in Translational Medicine
|October 22, 2016
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells
07:48

Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells

Published on: September 6, 2018

8.1K
Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery
05:00

Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery

Published on: December 20, 2010

11.6K

Related Experiment Videos

Last Updated: Mar 13, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K
Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells
07:48

Engineering Transplantation-suitable Retinal Pigment Epithelium Tissue Derived from Human Embryonic Stem Cells

Published on: September 6, 2018

8.1K
Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery
05:00

Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery

Published on: December 20, 2010

11.6K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Gene Therapy00:59

Gene Therapy

4.7K
4.7K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

17.5K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.5K

Articles linked to this work by shared authors, journal, and citation graph.

Cell therapy for prenatal repair of myelomeningocele: A systematic review.

Current research in translational medicine·2020

Pro-angiogenic effect of RANTES-loaded polysaccharide-based microparticles for a mouse ischemia therapy.

Scientific reports·2017

Hypoxia inducible factor one alpha and human viral pathogens.

Current research in translational medicine·2017

18F-FDG labelling of hematopoietic stem cells: Dynamic study of bone marrow homing by PET-CT imaging and impact on cell functionality.

Current research in translational medicine·2016

[Chronic fatigue syndrome: A new disorder?]

La Revue de medecine interne·2016

Update of the human parvovirus B19 biology.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2016

Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology.

Current research in translational medicine·2026

Non-invasive differentiation between aplastic anemia and myelodysplastic syndromes based on an 8-feature lightGBM model: A multicenter external validation study.

Current research in translational medicine·2026

Non-culture based diagnostic tests for detection of bacterial infections in hematology patients with febrile neutropenia: A review by the European Conference on Infections in Leukemia (ECIL-10).

Current research in translational medicine·2026

Efficacy and safety of CD19 CAR T-cell therapy in relapsed/refractory follicular lymphoma: A systematic review and meta-analysis.

Current research in translational medicine·2026

Allogeneic mesenchymal stem cell therapy combined with photobiomodulation for neonatal soft-tissue necrosis: A case report.

Current research in translational medicine·2026

Detection of acute lymphocytic and myeloid leukaemia with optimized dimensionality reduction and deep learning classification framework.

Current research in translational medicine·2026

The Influence of Meteorological Variables on the Occurrence of Deep Venous Thrombosis.

La Tunisie medicale·2026

Deep versus shallow decompression stops: illustration of different decompression strategies used in technical diving.

International maritime health·2026

Generation of the second mode in the hypersonic boundary layer by wavy wall.

The Journal of the Acoustical Society of America·2026

Preliminary experience with the transoral endoscopic thyroidectomy vestibular approach in selected complex cases: a case series and literature review.

Frontiers in surgery·2026

Arterial shear rate determines the structure and mechanical properties of whole-blood clots.

Research and practice in thrombosis and haemostasis·2026

Machine Perfusion and Mitigating Risk Factors for Delayed Graft Function in Pediatric Kidney Transplant Recipients.

Pediatric transplantation·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us